Related Experiment Video
Updated: Aug 30, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
The inhibitors of apoptosis: there is more to life than Bcl2
Peter Liston1, Wai Gin Fong, Robert G Korneluk
1Children's Hospital of Eastern Ontario, Research Institute, 401 Smyth Raod, Ottawa, Canada K1H 8L1.
Abstract:
The inhibitor of apoptosis (IAP) genes constitute a highly conserved family found in organisms as diverse as insects and mammals. These genes encode proteins that directly bind and inhibit caspases, and thus play a critical role in deciding cell fate. The IAPs are in turn regulated by endogenous proteins (second mitochondrial activator of caspases and Omi) that are released from the mitochondria during apoptosis. Overexpression of the IAPs, particularly the X-chromosome-linked IAP, has been shown to be protective in a variety of experimental animal models of human neurodegenerative diseases. Furthermore, overexpression of one or more of the IAPs in cancer cell lines and primary tumor samples appears to be a frequent event. IAP gene amplification and translocation events provide genetic evidence that further strengthens the case for classifying the IAPs as oncogenes. Therapeutic strategies that interfere with IAP expression or function are under investigation as an adjuvant to conventional chemotherapy- and radiation-based cancer therapy. This paper reviews the structure and function of the IAP family members and their inhibitors, and surveys the available evidence for IAP dysregulation in cancer.
Insights
Inhibitors of apoptosis (IAPs) regulate cell death and are often overexpressed in cancers, acting as oncogenes. Targeting IAPs offers a promising strategy for cancer therapy.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Inhibitor of apoptosis (IAP) proteins are conserved regulators of programmed cell death (apoptosis).
- IAPs directly inhibit caspases, crucial executioners of apoptosis, thereby controlling cell fate.
- Endogenous proteins, such as second mitochondrial activator of caspases and Omi, regulate IAP function.
Purpose of the Study:
- To review the structure and function of IAP family members and their inhibitors.
- To survey evidence for IAP dysregulation in cancer.
- To discuss the role of IAPs as oncogenes and potential therapeutic targets.
Main Methods:
- Literature review of IAP structure, function, and regulation.
- Analysis of experimental data on IAP overexpression in neurodegenerative disease models.
- Examination of genetic evidence (amplification, translocation) and expression data in cancer.
Main Results:
- IAP overexpression is protective in neurodegenerative disease models.
- IAP overexpression is frequent in cancer cell lines and tumors.
- Genetic alterations support classifying IAPs as oncogenes.
Conclusions:
- IAPs play a critical role in cell fate determination.
- IAP dysregulation, particularly overexpression, is implicated in oncogenesis.
- Targeting IAP function represents a potential adjuvant cancer therapy strategy.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
The Extrinsic Apoptotic Pathway
Apoptosis
Caspases
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.

